Foresee Pharmaceuticals announced that it has entered into an exclusive license agreement with GenScience Pharmaceuticals - a wholly-owned subsidiary of Changchun High-Tech Industry (Group) Co., Ltd. - for the commercialization of Foresee's novel FP-001..